170
Views
7
CrossRef citations to date
0
Altmetric
Articles

Effect of Perceived Stigma on Adherence to Highly Active Antiretroviral Therapy and Self-Confidence to Take Medication Correctly in Addis Ababa, Ethiopia

, &
Pages 346-362 | Published online: 19 Nov 2012
 

Abstract

Stigma has been a major barrier to accessing HIV prevention, care, and treatment services. This study seeks to assess the effect of stigma on self-reported adherence to highly active antiretroviral therapy (HAART) and self-confidence to take medication correctly among HIV-infected adults in Addis Ababa, Ethiopia. A descriptive cross-sectional study using both quantitative and qualitative data was carried out at Zewditu Memorial Hospital's HAART clinic. Self-reported Morisky scale was used to assess adherence to HAART, and Berger stigma scale was used to measure the level of perceived stigma. The three measures of stigma (negative self-image, concern about public attitude, and concern about disclosure) were negatively associated with self-reported adherence to HAART and with self-confidence to take medication correctly. In order to improve adherence, programs that address stigma need to be designed and implemented.

Notes

a Percentage rounded to 1 decimal point.

b 1 USD is equivalent to 16.38 Birr at the time of study.

a Sum of four questions with five scales.

b Sum of three questions with four scales.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.